Literature DB >> 838519

Long-term administration of DDT or phenobarbital-Na in Wistar rats.

L Rossi, M Ravera, G Repetti, L Santi.   

Abstract

In lifespan studies, outbred male and female Wistar rats were given either technical DDT mixed into the diet at a dose of 500 parts per million (ppm) or phenobarbital-sodium dissolved in drinking water at a dose of 500 ppm. Liver-cell tumors developed in treated animals but not in controls. The incidence of liver tumors was 45% in the DDT-treated group and 44% in the phenobarbital-sodium-group. When evaluated by sex, DDT-treated females and males had incidences of 56% and 35%, respectively, while in the phenobarbital-sodium group, the respective incidences were 32% and 59% in females and males. These data show a varying susceptibility between the sexes, with regard to induction of liver-cell tumors by the two compounds. In both treated groups, the number of nodular tumors per rat and the average size increased with age and were greater in females. None of these tumors and metastasized. Histologically, the liver tumors were nodular growths, which compressed surrounding parenchyma did not infiltrate it. The total incidence of extrahepatic tumors was higher in controls than in treated animals. In this connection, we must mention the apparent, but not significant, reduction of adrenal tumors in treated rats compared to the controls.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838519     DOI: 10.1002/ijc.2910190207

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma.

Authors:  E Christina Persson; Barry I Graubard; Alison A Evans; W Thomas London; Jean-Philippe Weber; Alain LeBlanc; Gang Chen; Wenyao Lin; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2012-03-15       Impact factor: 7.396

2.  Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.

Authors:  June K Dunnick; A Brix; H Cunny; M Vallant; K R Shockley
Journal:  Toxicol Pathol       Date:  2012       Impact factor: 1.902

Review 3.  Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.

Authors:  Brian G Lake
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

4.  Assessment of hepatic initiation-promotion properties of trichloroacetic acid.

Authors:  M J Parnell; J H Exon; L D Koller
Journal:  Arch Environ Contam Toxicol       Date:  1988-07       Impact factor: 2.804

Review 5.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

6.  Effect of phenobarbital on the development of neoplastic lesions in the liver of cycasin-treated rats.

Authors:  E Uchida; I Hirono
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Development of in vitro toxicity tests with cultures of freshly isolated rat hepatocytes.

Authors:  P Maier
Journal:  Experientia       Date:  1988-10-15

8.  Dose-response relationship for phenobarbitone promotion of liver tumours initiated by single dose dimethylnitrosamine.

Authors:  H E Driver; A E McLean
Journal:  Br J Exp Pathol       Date:  1986-02

9.  Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.

Authors:  Pamela K Ross; Courtney G Woods; Blair U Bradford; Oksana Kosyk; Daniel M Gatti; Michael L Cunningham; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-24       Impact factor: 4.219

10.  An integrated functional genomic study of acute phenobarbital exposure in the rat.

Authors:  Claire L Waterman; Richard A Currie; Lisa A Cottrell; Jacky Dow; Jayne Wright; Catherine J Waterfield; Julian L Griffin
Journal:  BMC Genomics       Date:  2010-01-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.